Champions Oncology Inc. announced on February 18, 2025, that seventeen abstracts have been accepted for presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting. The conference is scheduled to take place in Chicago, IL, from April 25-30, 2025.
These presentations will highlight Champions Oncology's cutting-edge research across various innovative platforms. The accepted abstracts feature advancements in in vivo and organoid platforms, which are utilized for oncology and immuno-oncology drug testing.
Furthermore, the presentations will include insights into the company's AI-driven models. These models leverage multi-omics datasets to predict patient outcomes, demonstrating Champions Oncology's commitment to integrating advanced computational approaches into cancer research.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.